Advertisement
New Zealand markets close in 1 hour 57 minutes
  • NZX 50

    11,769.51
    +41.50 (+0.35%)
     
  • NZD/USD

    0.6073
    -0.0013 (-0.21%)
     
  • NZD/EUR

    0.5586
    -0.0007 (-0.12%)
     
  • ALL ORDS

    7,924.70
    -0.50 (-0.01%)
     
  • ASX 200

    7,673.70
    -2.10 (-0.03%)
     
  • OIL

    82.56
    -0.16 (-0.19%)
     
  • GOLD

    2,162.90
    -1.40 (-0.06%)
     
  • NASDAQ

    17,985.01
    +176.76 (+0.99%)
     
  • FTSE

    7,722.55
    -4.87 (-0.06%)
     
  • Dow Jones

    38,790.43
    +75.66 (+0.20%)
     
  • DAX

    17,932.68
    -3.97 (-0.02%)
     
  • Hang Seng

    16,554.10
    -183.02 (-1.09%)
     
  • NIKKEI 225

    39,462.78
    -277.66 (-0.70%)
     
  • NZD/JPY

    90.6560
    -0.0390 (-0.04%)
     

Moderna Stock: Buy, Sell, or Hold in 2023?

Moderna Stock: Buy, Sell, or Hold in 2023?

Moderna (NASDAQ: MRNA) shares delivered top returns to investors in the earlier days of the pandemic. This year, though, the stock is heading for a 30% loss, even though Moderna's coronavirus vaccine generates billions in revenue and profit. Looking ahead to 2023, you might be wondering whether Moderna's best days are in the past -- or if this vaccine maker still presents an opportunity.